Vident Advisory LLC Increases Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Vident Advisory LLC lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 132.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,789 shares of the company's stock after buying an additional 15,262 shares during the quarter. Vident Advisory LLC's holdings in Option Care Health were worth $622,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Murphy & Mullick Capital Management Corp purchased a new stake in shares of Option Care Health in the fourth quarter valued at approximately $26,000. UMB Bank n.a. boosted its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after buying an additional 346 shares in the last quarter. Signaturefd LLC boosted its stake in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after buying an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC boosted its stake in shares of Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after buying an additional 1,099 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in Option Care Health during the fourth quarter worth $47,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on OPCH shares. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Price Performance

Shares of NASDAQ OPCH traded up $0.42 during trading on Friday, reaching $32.68. The company had a trading volume of 169,061 shares, compared to its average volume of 1,853,521. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The stock has a market capitalization of $5.35 billion, a PE ratio of 27.46, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The stock has a 50-day moving average price of $32.78 and a two-hundred day moving average price of $29.55. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same period in the previous year, the firm posted $0.26 earnings per share. The business's revenue for the quarter was up 16.3% compared to the same quarter last year. As a group, sell-side analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.